Q3 EPS Estimates for Eton Pharmaceuticals Cut by B. Riley
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Free Report) – Stock analysts at B. Riley dropped their Q3 2025 earnings estimates for Eton Pharmaceuticals in a research note issued on Thursday, May 15th. B. Riley analyst M. El-Saadi now expects that the company will post earnings per share of $0.10 for the quarter, down from their prior […]
